Derin Anugrah Pratama (@derinbnd) header
Derin Anugrah Pratama (@derinbnd) profile picture

Dokter dalem (Internis).

Jakarta
Joined March 2010
Photo by Derin Anugrah Pratama (@derinbnd)Photo by Derin Anugrah Pratama (@derinbnd)Photo by Derin Anugrah Pratama (@derinbnd)Photo by Derin Anugrah Pratama (@derinbnd)Photo by Derin Anugrah Pratama (@derinbnd)Photo by Derin Anugrah Pratama (@derinbnd)Photo by Derin Anugrah Pratama (@derinbnd)Photo by Derin Anugrah Pratama (@derinbnd)Photo by Derin Anugrah Pratama (@derinbnd)Photo by Derin Anugrah Pratama (@derinbnd)
Derin Anugrah Pratama retweeted
When is CML truly “resistant” or “relapsed,” and how should it be managed? doi.org/10.1182/blood.202402… 1️⃣CML resistance is defined by molecular response milestones, not by symptoms. Key BCR::ABL1 (IS) targets: • ≤10% at 3 months (expected early response) • ≤1% at 6 months • ≤0.1% (MR3) at 12 months 🚨 ELN failure (therapy change required): • >10% at 6 months • ≥1% at 12 months or later 🚨 NCCN “red flags”: • Persistent >10% at 6–12 months • Loss of prior hematologic, cytogenetic, or molecular response ➡️ Failure = inadequate depth OR loss of response → reassess and change TKI ⸻ 2️⃣Before calling it resistance, rule out pseudo-resistance (very common): ❌ Non-adherence 💊 Drug–drug interactions ⏸️ Dose reductions or interruptions due to toxicity 🧪 Poor monitoring or lab variability 🔑 Always correct these before switching TKIs. ⸻ 3️⃣Mutation testing is the single most important next step • Perform NGS (preferred) at any failure or loss of response • Mutations mainly exclude TKIs (what NOT to use) rather than selecting one perfect drug ⸻ Choosing the next TKI (stepwise, risk-adapted): • Imatinib failure → 2G TKI (dasatinib, nilotinib, bosutinib) or asciminib • 2G TKI failure → ponatinib or asciminib preferred • ≥2 TKIs or T315I → dose-adjusted ponatinib OR asciminib • Consider allo-HCT only for true multi-TKI resistance 🧠 Asciminib now has a growing role across multiple lines, including earlier use in selected patients. ⸻ 4️⃣Big picture takeaway: 🔴 In chronic-phase CML, survival is driven by TKIs. 🔴 Transplant is reserved for failure, not choice. 📌 Failure → reassess milestones → fix pseudo-resistance → test mutations → change therapy.
1
11
36
1,677
Derin Anugrah Pratama retweeted
Dokter Tri Maharani merupakan satu-satunya dokter ahli gigitan ular berbisa di Indonesia. Dia membagikan pertolongan pertama yang harus dilakukan setelah digigit ular. bbc.com/indonesia/articles/c…
53
2,452
137
5,428
307,791
Derin Anugrah Pratama retweeted
Lah bukannya udah ada aturannya? 1) Ambil PPDS Obgyn 2) Selesaikan pendidikan, 4-5 tahun 3) Setelah itu bisa tangani operasi caesar Ngapain bikin aturan yang udah ada?
Menkes Akan Siapkan Aturan Dokter Umum Tangani Operasi Caesar
101
1,408
51
6,629
325,715
Bukan, saya bukan Priguna.. Nerbener mencemarkan nama baik klan Anugrah Pratama 🥲😭
2
1
4,122
Hahaha lucu bgt lagi masuk jurnal jama. Seringkali politician approach. 😂😂😂
Newly joining residents, read this👇 🎈PIMPING occurs when an attending physician (the Pimper) poses a series of difficult questions to a resident or medical student (the Pimpee) during ward rounds. How to negotiate PIMPING? 🤣🤣🤣 jamanetwork.com/journals/jam…
350
Derin Anugrah Pratama retweeted
Internal Medicine residents🤣🤣🤣
17
208
16
1,100
67,306
Pasien dengan kanker semakin banyak. Semula mengandalkan kemoterapi saja namun semakin kesini obat-obat semakin berkembang pula utk menargetkan berbagai reseptor. Namun sayangnya belum banyak yg ditanggung BPJS. Apa yang perlu dibenahi?
261
New workplace.. Bismillaah
2
1
362
Derin Anugrah Pratama retweeted
🌟 ORAL HYPOGLYCEMIC DRUGS - Dosing in CKD 🔸️As per latest recommendations Dapagliflozin can be initiated at eGFR > 20 and continued till RRT. Also pioglitazone doesn't require dose adjustment for any stage of CKD.
11
156
600
75,478
Derin Anugrah Pratama retweeted
👌SGLT2 Inhibitors Use recommendations @bmj_latest
2
149
610
51,467
Derin Anugrah Pratama retweeted
🚨AGA New Guideline Alert🚨 🔗gastrojournal.org/article/S0… ▶️AGA Living Guideline: Pharmacological Management of Moderate-Severe Ulcerative Colitis I’ll break down its 14 recommendations down over the next 7 tweets 🧵 👇 #AGA #GI #UC #IBD #MedTwitter 1/9
9
106
6
325
38,909
Bahagia itu sesederhana pasien kontrol gaada keluhan, lab nya bagus gaada yg merah 🤗
107
“It’s not that people change, but we eventually get to know them better.” Cr: @bersuarakan
145
Baru nonton dan gila bgt ini film!!
152
Derin Anugrah Pratama retweeted
#Becareful 🔴 ⚠️ Stroke. Vertebral artery dissection. Very common at chiropractor clinics, spa massage centres, Barbar shops, and street massagers! #NeuroMed #MedEd #MedX
120
1,383
245
3,476
1,807,763
Derin Anugrah Pratama retweeted
tidak pernah cetak, manfaatkan Zotero (iPad) sebaik mungkin untuk baca artikel serius. highlight semua sampai selesai. lalu mencatat ulang di Logseq (MarkDown) untuk bangun Second Brain. Logseq juga terhubung ke Zotero. saat nulis beneran, Logseq+Zotero ke LaTeX Overleaf.
Kalo baca "serius" mesti ngeprint dulu ini apakah problem generasi... 🥴🥲
75
1,540
234
11,991
1,001,311
Derin Anugrah Pratama retweeted
1/9 A 33 y/o F with carpal tunnel syndrome presents with polyuria and polydipsia. She has a fasting serum glucose of 212 mg/dL and a hemoglobin a1c of 9.7%. Do you have an approach to hyperglycemia?
19
129
14
792
166,952
Peran Penghambat SGLT-2 dalam koreksi anemia. Kenalan sama obat canggih ini yg bener-bener dipake di berbagai kasus, antara lain; Gagal jantung kronik, gagal ginjal kronik, diabetes mellitus dengan penyulit, ditambah bonus naikin Hb.
1
378
Sedikit sharing mengenai rendahnya kadar trombosit pada kehamilan (GT), dapat ditemukan pada 7-11% kehamilan, biasanya di trimester 3. #trombositopenia #kehamilan
1
194